首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Characterization of a Novel Murine Colon Carcinoma Subline with High-Metastatic Activity Established by In Vivo Selection Method
【2h】

Characterization of a Novel Murine Colon Carcinoma Subline with High-Metastatic Activity Established by In Vivo Selection Method

机译:通过体内选择方法建立的具有高转移活性的新型小鼠结肠癌亚系的表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The establishment of cancer cell lines, which have different metastatic abilities compared with the parental cell, is considered as an effective approach to investigate mechanisms of metastasis. A highly metastatic potential mouse colon cancer cell subline, Colon-26MGS, was derived from the parental cell line Colon-26 by in vivo selection using continuous subcutaneous implanting to immunocompetent mice. To clarify the mechanisms involved in the enhancement of metastasis, morphological characteristics, cell proliferation, and gene expression profiles were compared between Colon-26MGS and the parental cell. Colon-26MGS showed over 10 times higher metastatic ability compared with the parental cell, but there were no differences in morphological characteristics and in vitro proliferation rates. In addition, the Colon-26MGS-bearing mice exhibited no marked change of splenocyte population and lung pre-metastatic niche with tumor-free mice, but there were significant differences compared to Colon-26-bearing mice. RNA-seq analyses indicated that immune costimulatory molecules were significantly up-regulated in Colon-26MGS. These results suggest that Colon-26MGS showed not only higher metastatic activity, but also less induction property of host immune response compared to parental Colon-26. Colon-26MGS has proven to be a novel useful tool for studying multiple mechanisms involving metastasis enhancement.
机译:与亲代细胞相比具有不同转移能力的癌细胞系的建立被认为是研究转移机制的有效方法。通过对免疫活性小鼠进行连续皮下植入的体内选择,从亲本细胞系Colon-26衍生出具有高度转移潜力的小鼠结肠癌细胞亚系Colon-26MGS。为了弄清参与转移增强的机制,在Colon-26MGS和亲代细胞之间比较了形态特征,细胞增殖和基因表达谱。 Colon-26MGS的转移能力比亲代细胞高10倍以上,但形态特征和体外增殖率没有差异。此外,与无结肠癌的小鼠相比,有结肠26MGS的小鼠脾脏细胞数量和肺转移前的生态位没有明显变化,但与有结肠26的小鼠相比有显着差异。 RNA-seq分析表明,免疫共刺激分子在Colon-26MGS中显着上调。这些结果表明,与亲本Colon-26相比,Colon-26MGS不仅显示出更高的转移活性,而且还表现出更少的宿主免疫应答诱导特性。已证明Colon-26MGS是研究涉及转移增强的多种机制的新颖有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号